NOVATO, California, April 29 /PRNewswire/ --

- Claims to Cover Therapeutic Delivery Across Blood-Brain Barrier

Raptor Pharmaceuticals Corp. (Raptor or the Company) (OTC Bulletin Board: RPTP) today announced that the United States Patent and Trademark Office (USPTO) has issued two Notices of Allowance for U.S. Patent Application Nos. 10/812,849 and 11/202,566, titled Methods of increasing delivery of active agents to brain comprising administering receptor-associated protein (RAP) fragments conjugated to active agents.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO)

GUANGZHOU, China, April 29 /PRNewswire/ --

Visiting the Canton Fair this year, you might feel lost in the crowd. With hundreds of thousands of buyers, tens of thousands of suppliers, and hundreds of nationalities trading a wide variety of products, it might seem as though your only points of connection are pre-arranged online. But there are two things that link the Chinese Machinery salesman, the Saudi Arabian textile buyer, and the American conglomerate: they have the desire to expand in a tough market, and they know that China is still the place to go to fulfill their ambitions.

TORONTO, April 29 /PRNewswire/ --

- Million-Dollar Deal Sees European Operator Among First to Offer Subscribers Benefits of Flexible Pricing Plans and Fair-Usage

Redknee (TSX: RKN), a leading provider of mission-critical software and solutions for communications service providers, today announced that a European wireless operator will be the first to deploy Redknee's newly enhanced Next Generation Rating and Charging (NGRC) platform, version 6.0. Redknee's newest release of NGRC enables operators to provide flexible tiered offerings and dynamic subscriber controls for mobile data and broadband services.

STOCKHOLM, Sweden, April 29 /PRNewswire/ --

- Results to be Presented at World Congress of Nephrology 2009

Pharmalink AB announced today that it has completed its open Phase II trial evaluating the efficacy and safety of Nefecon(R) in IgA nephropathy, a glomerulonephritis leading to end-stage renal disease. Nefecon is an enteric formulation of a locally acting corticosteroid which downregulates the inflammatory process in the kidneys through suppression of the gut immune system.

ST. LOUIS, Missouri, April 29 /PRNewswire/ --

- Increases Accessibility to Market-Leading Specialty Content

Elsevier, the world's leading publisher of scientific, technical, and medical information products and services, announced today that ten new eBook Specialty Collections have launched on MD Consult (http://www.mdconsult.com), its online clinical reference tool. This launch provides online availability of market-leading specialty content in Dermatology, Dermatologic Surgery, Family Medicine, General Radiology, Geriatric Medicine, Hand Surgery, Neonatology, Otolaryngology, Pathology, and Shoulder Surgery.

ROTTERDAM, Netherlands and MUNICH, Germany, April 29 /PRNewswire/ --

- Conference in Munich, Germany Will Include Chief Executives of World's Largest Solar Manufacturers, Top Investors and Analysts

- Forecast for Solar Industry in Coming Years Revealed, Rare Opportunity for High-Level Networking

LONDON, April 29 /PRNewswire/ --

Bulgaria offers immense growth potential for electronics manufacturing and related services. However, high inflation has been a cause of concern, especially amidst the economic slowdown, which affected Bulgaria in the second half of 2008. Nevertheless, contract manufacturers in Bulgaria can look forward to mixed prospects in 2009 with more market opportunities projected to emerge in 2010, thanks to incentives offered by the government promoting electronics manufacturing.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

SYDNEY, April 29 /PRNewswire/ --

- To Receive Milestone Payments from Quest Diagnostics

NEW YORK, April 29 /PRNewswire/ --

- Prestigious training academy for young musicians commemorates fifth anniversary by launching onto world stage